ArticleVeterinary surgery : VS2026
Delivery of AgNP led to more pronounced local retention in the subcutaneous versus intraperitoneal location with limited uptake and toxic effects in rats.
Article in Veterinary surgery : VS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveTo determine adverse effects of intraperitoneally (IP) or subcutaneously (SC) delivered silver nanoparticles (AgNP) in poloxamer 407 (P407; AgNP-P407) and local retention and systemic uptake in rats. STUDY
designControlled randomized trial. ANIMALS: A total of 25 rats.
methodsA total of 10 rats were randomly assigned in Phase 1 to a SC or IP surgical delivery group (5 rats/group) to receive 0.01 mg AgNP/rat in P407 (1:2 volume ratio). A total of 15 rats (5/group) were used in Phase 2 to receive IP: gel only (1.0 mL), AgNP-P407 (0.01 mg AgNP in 1.0 mL P407) or AgNP (0.01 mg in aqueous buffer). Incisions were assessed daily. Euthanasia was performed on day 7. The SC surgery sites and organs were harvested and evaluated histologically with scores reported. Plasma was obtained and batch analyzed together with organs for Ag content using mass spectroscopy.
resultsAll rats survived the duration of the study. Minimal local histologic toxicity was seen after SC delivery. Plasma Ag peaked earlier for IP than SC delivery (p = .08) and for Ag delivered IP without gel (p = .04). Organ Ag uptake was minimal; macrophage aggregation was identified in the spleen and lymph node consistently. Rats that received P407 had increased cholesterol, whereas changes in total protein, albumin, glucose, amylase and lipase were seen for all groups.
conclusionNo adverse events were noted after use of AgNP-P407, while Ag uptake was delayed. CLINICAL RELEVANCE: Use of AgNP-P407 may be possible without systemic effects and prolonged local presence, but further testing is needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.